Business is booming.

Nigeria faring well in global biotechnology space – NBDA

By Omotayo Edubi

The National Biotechnology Development Agency (NBDA), says Nigeria is faring very well in global biotechnology space.

Dr Rose Gidado, the Deputy Director, Agricultural Biotechnology Department, NBDA, disclosed this in an interview on Thursday in Lagos.

Gidado said that biotechnology has come to stay in the country.

She expressed optimism that the recent signing of the Act establishing the NBDA by President Muhammadu Buhari would further spur the agency to do more.

Gidado said that biotechnology has a lot of benefits not only in agricultural sector but in the environment, medicine and industrial sector.

“We now have an Act establishing us but we have been in existence for over 20-years without it. Now that we have a legal backing, it will further spur us to do more.

“What this means is that we are being recognised. We are going to operate legally now and biotechnology has come to stay in Nigeria,” she said.

Gidado said that the benefits of biotechnology cut across many sectors of the economy.

“Biotechnology is not just in the area of agriculture, it is also in environment. It is used for environmental restoration, deforestation, mitigation of climate change effect, enhances the mitigation of green house gases.

“Also in the area of medicine, it is used for diagnostic, greater medicine, cheaper medicine and improved medicine service.

“It is used in the production of more enzymes and designing of food to meet the needs of some ailment like diabetes.

“Nigeria is faring very well in global biotechnology because we already have crops that have been comercialised,” she said.

below content

Quality journalism costs money. Today, we’re asking that you support us to do more. Support our work by sending in your donations.

The donation can be made directly into NatureNews Account below

Guaranty Trust Bank, Nigeria

0609085876

NatureNews Online

Leave a comment

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More